MTOR and breast carcinoma: According to the results of our molecular docking and transcriptome analysis, we have discovered that curcumin not only acts as a dual inhibitor of the PI3K/AKT/mTOR and RAF/MEK/ERK pathways in breast cancer cell lines, but it can also function as an inhibitor of multiple RTKs to deactivate downstream signaling pathways.